Medtronic is now the first company to offer two FDA-approved PFA systems for the treatment of persistent AFib. The company’s PulseSelect PFA system gained approval in December 2023.
The Evolut FX+ TAVR system, which already received FDA approval in March, was designed with improved coronary access in mind. One cardiologist described the device as a "significant step forward" for patients with heart disease.
Vegetarian and vegan diets can lower an adult's risk of developing or dying from CVD, according to a new umbrella review of 21 different studies. Researchers believe these findings should be used to influence patient guidelines going forward.
Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.
Many Americans have never heard of peripheral artery disease or other common vascular conditions. In fact, a vast majority are not sure what vascular surgeons do.
Four leading cardiothoracic surgery societies have joined forces in the name of developing clinical practice guidelines that are more thorough and consistent.
While production is relatively unchanged compared to the previous year, compensation is up significantly for cardiovascular surgeons in the United States.
